Cite
HARVARD Citation
Skelton, W. et al. (2018). Bevacizumab Eligibility in Patients with Metastatic and Recurrent Cervical Cancer: A Retrospective Review. Clinical medicine insights. Oncology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Skelton, W. et al. (2018). Bevacizumab Eligibility in Patients with Metastatic and Recurrent Cervical Cancer: A Retrospective Review. Clinical medicine insights. Oncology. p. . [Online].